324 related articles for article (PubMed ID: 27842894)
1. [Caution and warning: About valproate and pregnancy].
Masson M; Huberfeld G; Richa S; Henry C; Gaillard R
Encephale; 2016 Oct; 42(5):391-394. PubMed ID: 27842894
[No Abstract] [Full Text] [Related]
2. Preventive recommendations on the use of valproic acid in pregnant or gestational women to be very present.
García-Portilla MP; Bobes J
Rev Psiquiatr Salud Ment; 2017; 10(3):129-133. PubMed ID: 28688547
[No Abstract] [Full Text] [Related]
3. Dangers of valproate in pregnancy.
Wieck A; Jones S
BMJ; 2018 Apr; 361():k1609. PubMed ID: 29669728
[No Abstract] [Full Text] [Related]
4. Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review.
Reynolds MF; Sisk EC; Rasgon NL
Curr Med Chem; 2007; 14(26):2799-812. PubMed ID: 18045126
[TBL] [Abstract][Full Text] [Related]
5. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?
Perera C; Patterson S; Bruxner G
Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123
[TBL] [Abstract][Full Text] [Related]
6. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
[TBL] [Abstract][Full Text] [Related]
7. [A girl with foetal valproate syndrome and autism spectrum disorder].
Solignac I
Tijdschr Psychiatr; 2016; 58(3):228-31. PubMed ID: 26979855
[TBL] [Abstract][Full Text] [Related]
8. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
Macfarlane A; Greenhalgh T
BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057
[TBL] [Abstract][Full Text] [Related]
9. [Valproic acid during pregnancy lowers IQ in children].
Versicherungsmedizin; 2013 Sep; 65(3):172. PubMed ID: 24137907
[No Abstract] [Full Text] [Related]
10. Weighing the risks of valproate in women who could become pregnant.
Angus-Leppan H; Liu RSN
BMJ; 2018 Apr; 361():k1596. PubMed ID: 29669717
[No Abstract] [Full Text] [Related]
11. France steps up warning measures for valproate drugs.
Casassus B
Lancet; 2016 Mar; 387(10024):1148. PubMed ID: 27025323
[No Abstract] [Full Text] [Related]
12. [Position Statement of Hungarian Epilepsy League: The use of valproate preparations for epilepsy in pregnancy and in women of childbearing age].
Janszky J;
Ideggyogy Sz; 2015 Mar; 68(3-4):143. PubMed ID: 26434203
[No Abstract] [Full Text] [Related]
13. Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions.
Gentile S
CNS Spectr; 2014 Aug; 19(4):305-15. PubMed ID: 24571806
[TBL] [Abstract][Full Text] [Related]
14. Valproate and babies.
Whitehall J; Smith J
Aust N Z J Psychiatry; 2008 Sep; 42(9):837. PubMed ID: 18696289
[No Abstract] [Full Text] [Related]
15. Valproate use during pregnancy was linked to autism spectrum disorder and childhood autism in offspring.
Singh S
Ann Intern Med; 2013 Aug; 159(4):JC13. PubMed ID: 24026277
[No Abstract] [Full Text] [Related]
16. Prescribing in pregnancy shows the weaknesses in pharmacovigilance.
Braillon A; Bewley S
BMJ; 2018 May; 361():k2334. PubMed ID: 29844154
[No Abstract] [Full Text] [Related]
17. Longer term outcome of children born to mothers with epilepsy.
Shorvon SD
J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1517-8. PubMed ID: 15489379
[No Abstract] [Full Text] [Related]
18. Sodium valproate: who knew what and when? Cumulative meta-analysis gives extra insights.
Heneghan C; Aronson JK
BMJ Evid Based Med; 2019 Aug; 24(4):127-129. PubMed ID: 30348656
[No Abstract] [Full Text] [Related]
19. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
Smith V; Brown N
Arch Dis Child Educ Pract Ed; 2014 Oct; 99(5):198. PubMed ID: 24692263
[No Abstract] [Full Text] [Related]
20. Prenatal exposure to sodium valproate is associated with increased risk of childhood autism and autistic spectrum disorder.
Wood A
Evid Based Nurs; 2014 Jul; 17(3):84. PubMed ID: 23999195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
